Insiders · Profile

CALLICUTT JACK W

Chief Financial Officer at GALECTIN THERAPEUTICS. Filing since 19 Nov 2013. CIK 0001266773

Company
Date
Role
Action
Shares
Amount
Of holding
6 Jan 2026
Chief Financial Officer
Sold on a plan
20,354
$74.70K
72.8%
5 Jan 2026
Chief Financial Officer
Sold on a plan
25,732
$100.30K
47.9%
2 Jan 2026
Chief Financial Officer
Sold on a plan
13,914
$58.39K
20.6%
18 Nov 2025
Chief Financial Officer
Sold on a plan
46,310
$288.19K
85.9%
17 Nov 2025
Chief Financial Officer
Sold on a plan
31,610
$190.66K
80.6%
10 Nov 2025
Chief Financial Officer
Sold on a plan
5,291
$31.88K
41.0%
5 Nov 2025
Chief Financial Officer
Sold on a plan
600
$3.60K
7.3%
4 Nov 2025
Chief Financial Officer
Sold on a plan
28,629
$173.78K
79.0%
3 Nov 2025
Chief Financial Officer
Sold on a plan
3,810
$22.90K
33.4%
12 Sep 2025
Chief Financial Officer
Sold on a plan
8,706
$56.05K
53.3%
23 Dec 2024
Chief Financial Officer
Sold on a plan
40,000
$35.49K
84.0%
17 Nov 2022
Chief Financial Officer
Bought
4,000
$5.28K
111%
31 May 2019
Chief Financial Officer
Bought
2,354
$10.08K
187%
20 Jun 2018
Chief Financial Officer
Sold, plan not stated
97,267
$786.03K
98.7%
19 Jun 2018
Chief Financial Officer
Sold, plan not stated
128,733
$1.16M
99.0%
12 Jun 2018
Chief Financial Officer
Sold, plan not stated
9,294
$65.17K
88.1%
11 Jun 2018
Chief Financial Officer
Sold, plan not stated
20,000
$127.50K
94.1%
8 Jun 2018
Chief Financial Officer
Sold, plan not stated
100,000
$575.00K
98.8%
31 May 2018
Chief Financial Officer
Sold, plan not stated
46,651
$233.26K
97.4%
4 Apr 2018
Chief Financial Officer
Sold, plan not stated
3,349
$16.75K
72.7%
14 Aug 2014
Chief Financial Officer
Bought
1,000
$4.55K
385%
19 Nov 2013
Chief Financial Officer
Bought
260
$1.63K
opened
22 decisions on file.